Literature DB >> 23208896

Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage based on the analysis of on-admission information.

Wu Cong1, Zhao Zhongxin, Li Tiangui, Yu Zhang, He Min, You Chao.   

Abstract

AIM: To provide a quick evaluation of rebleeding risk based on the on-admission patient information and to guide the management of patients for better outcome.
MATERIAL AND METHODS: A retrospective review of 630 consecutive cases of subarachnoid hemorrhage (SAH) at a major medical center was conducted, of which 458 were included for analysis. Sixty three cases of in-hospital pre-intervention rebleeding were identified. Chi-square or Mann-Whitney tests were used to screen for possible risk factors and values of the associated risk factors were assessed by logistic multivariate regression.
RESULTS: The identified risk factors were: short time interval between the first attack and hospitalization, gender (males were more susceptible), poor Hunt-Hess grade (III~V), high systolic pressure ( > 140 mmHg), intracerebral or intraventricular hematoma, high level of serum glucose ( > 6.32 mmol/L) and high white blood cell count ( > 12 x 10^9/L). Use of antifibrinolysis medication did not differ between groups. Subgroup analysis showed that posterior circulation aneurysms had a significantly higher rebleeding rate. Logistic regression analysis showed that intracerebral or intraventricular hematoma (p=0.010, OR=1.478) and blood glucose level above 6.32 mmol/L (p=0.011, OR=2.126) were independent risk factors.
CONCLUSION: We found a particularly high risk of rebleeding in patients with intracerebral or intraventricular hematoma or relatively high serum glucose level on admission. Posterior circulation aneurysms rebleed seemed more prominently manifested. An earlier and more aggressive intervention may be applied to patients at high risk.

Entities:  

Mesh:

Year:  2012        PMID: 23208896     DOI: 10.5137/1019-5149.JTN.5054-11.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  7 in total

1.  Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study.

Authors:  Sebastian Szklener; Anna Melges; Agnieszka Korchut; Wojciech Zaluska; Tomasz Trojanowski; Robert Rejdak; Konrad Rejdak
Journal:  BMJ Open       Date:  2015-06-12       Impact factor: 2.692

Review 2.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Won-Sang Cho; Jeong Eun Kim; Sukh Que Park; Jun Kyeung Ko; Dae-Won Kim; Jung Cheol Park; Je Young Yeon; Seung Young Chung; Joonho Chung; Sung-Pil Joo; Gyojun Hwang; Deog Young Kim; Won Hyuk Chang; Kyu-Sun Choi; Sung Ho Lee; Seung Hun Sheen; Hyun-Seung Kang; Byung Moon Kim; Hee-Joon Bae; Chang Wan Oh; Hyeon Seon Park
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

3.  Elevated Glucose-Potassium Ratio Predicts Preoperative Rebleeding in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Jiayin Wang; Qiangqiang Feng; Yinbin Zhang; Weizhi Qiu; Hongzhi Gao
Journal:  Front Neurol       Date:  2022-01-13       Impact factor: 4.003

4.  Rebleeding in aneurysm after rectal enema: Re-emphasis on careful subarachnoid hemorrhage management.

Authors:  Suraj Shrestha; Akash Raut; Sushan Homagain; Gopal Sedain; Rupesh Ramtel
Journal:  Clin Case Rep       Date:  2021-07-23

Review 5.  Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis.

Authors:  Chao Tang; Tian-Song Zhang; Liang-Fu Zhou
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

6.  Evaluation of the Efficacy and Safety of Short-Course Deep Sedation Therapy for the Treatment of Intracerebral Hemorrhage After Surgery: A Non-Randomized Control Study.

Authors:  Dapeng Hou; Beibei Liu; Juan Zhang; Qiushi Wang; Wei Zheng
Journal:  Med Sci Monit       Date:  2016-07-28

Review 7.  Determining rural risk for aneurysmal subarachnoid hemorrhages: A structural equation modeling approach.

Authors:  Linda Jayne Nichols; Seana Gall; Christine Stirling
Journal:  J Neurosci Rural Pract       Date:  2016 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.